BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 27398087)

  • 1. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.
    Bock P; Fatti G; Ford N; Jennings K; Kruger J; Gunst C; Louis F; Grobbelaar N; Shanaube K; Floyd S; Grimwood A; Hayes R; Ayles H; Fidler S; Beyers N;
    PLoS One; 2018; 13(4):e0195127. PubMed ID: 29672542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study.
    Dorward J; Sookrajh Y; Gate K; Khubone T; Mtshaka N; Mlisana K; Ngobese H; Yende-Zuma N; Garrett N
    J Int AIDS Soc; 2020 Apr; 23(4):e25479. PubMed ID: 32319203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis.
    Minn AC; Kyaw NTT; Aung TK; Mon OM; Htun T; Oo MM; Moe J; Mon AA; Satyanarayana S; Oo HN
    Glob Health Action; 2018; 11(1):1510593. PubMed ID: 30191749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of attrition among adults in a rural HIV clinic in southern Mozambique: 18-year retrospective study.
    Nacarapa E; Verdu ME; Nacarapa J; Macuacua A; Chongo B; Osorio D; Munyangaju I; Mugabe D; Paredes R; Chamarro A; Revollo B; Alexandre SS; Simango M; Torrus D; Ramos-Rincon JM
    Sci Rep; 2021 Sep; 11(1):17897. PubMed ID: 34504234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved retention of patients starting antiretroviral treatment in Karonga District, northern Malawi, 2005-2012.
    Koole O; Houben RM; Mzembe T; Van Boeckel TP; Kayange M; Jahn A; Chimbwandira F; Glynn JR; Crampin AC
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):e27-e33. PubMed ID: 24977375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persons living with HIV with advanced HIV disease: need for novel care models.
    Teasdale CA; Yuengling K; Preko P; Syowai M; Ndagije F; Rabkin M; Abrams EJ; El-Sadr WM
    J Int AIDS Soc; 2018 Dec; 21(12):e25210. PubMed ID: 30549245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention in care among clinically stable antiretroviral therapy patients following a six-monthly clinical consultation schedule: findings from a cohort study in rural Malawi.
    Wringe A; Cawley C; Szumilin E; Salumu L; Amoros Quiles I; Pasquier E; Masiku C; Nicholas S
    J Int AIDS Soc; 2018 Nov; 21(11):e25207. PubMed ID: 30450699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
    Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
    PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.
    Alhaj M; Amberbir A; Singogo E; Banda V; van Lettow M; Matengeni A; Kawalazira G; Theu J; Jagriti MR; Chan AK; van Oosterhout JJ
    J Int AIDS Soc; 2019 Feb; 22(2):e25239. PubMed ID: 30734510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from Eswatini.
    Kerschberger B; Jobanputra K; Schomaker M; Kabore SM; Teck R; Mabhena E; Lukhele N; Rusch B; Boulle A; Ciglenecki I
    J Int AIDS Soc; 2019 Oct; 22(10):e25401. PubMed ID: 31647613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion and scale-up of HIV care and treatment services in four countries over ten years.
    Teasdale CA; Abrams EJ; Yuengling KA; Lamb MR; Wang C; Vitale M; Hawken M; Melaku Z; Nuwagaba-Biribonwoha H; El-Sadr WM
    PLoS One; 2020; 15(4):e0231667. PubMed ID: 32298331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.
    Stockdale AJ; Nkuranga J; Török ME; Faragher B; Lalloo DG
    Trop Med Int Health; 2013 Jul; 18(7):907-14. PubMed ID: 23590229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
    Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
    PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.